How effective is ablation therapy for cardiac arrhythmias?

2013 ◽  
Vol 10 (2) ◽  
pp. 177-187 ◽  
Author(s):  
Laurent Pison ◽  
Harry J Crijns
Keyword(s):  
Cardiac Arrhythmias ◽  
Ablation Therapy

Ablation Therapy for Cardiac Arrhythmias

1997 ◽  
Vol 80 (8) ◽  
pp. 56G-66G ◽  
Author(s):  
William G Stevenson ◽  
Kristin E Ellison ◽  
David C Lefroy ◽  
Peter L Friedman
Keyword(s):  
Cardiac Arrhythmias ◽  
Ablation Therapy

Sleep and cardiac arrhythmias

1972 ◽  
Vol 130 (5) ◽  
pp. 751-753 ◽  
Author(s):  
R. Smith
Keyword(s):  
Cardiac Arrhythmias

Cardiac arrhythmias related to psychiatric medication

2017 ◽  
Vol 36 (09) ◽  
pp. 747-750
Author(s):  
R. W. Freudenmann ◽  
C. Schönfeldt-Lecuona ◽  
B. J. Connemann ◽  
M. Gahr ◽  
M. Elsayed
Keyword(s):  
Cardiac Arrhythmias ◽  
Torsade De Pointes ◽  
General Medicine ◽  
Fold Increase ◽  
Cardiac Risk ◽  
Psychiatric Medication ◽  
Cardiac Side Effects ◽  
Torsade De Pointes Tachycardia ◽  
Multiple Drugs ◽  
Available Information

SummaryThis narrative review summarizes current available information about cardiac arrhythmias (QT prolongation, Torsade de pointes Tachycardia [TdP], sudden cardiac death) associated with psychiatric medication. Among the most commonly used antipsychotics, amisulpride and ziprasidone are most frequently associated with TdP. Treatment with some antidepressants (SSRIs, tricyclic antidepressants) is associated with a 5- to 6-fold increase in the incidence of out-of-hospital cardiac arrest. Lithium is associated with bradycardia, T-wave changes and AV-block; anxiolytics of the benzodiazepine group do usually not have cardiac side effects. The combination of multiple drugs (including medications from general medicine) that prolong the QT interval has a particularly high cardiac risk.

Sign in / Sign up

Export Citation Format

Share Document